AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 141 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $15,650,000 | +1183.8% | 261,538 | +502.9% | 0.43% | +1396.6% |
| Q3 2019 | $1,219,000 | +33.4% | 43,380 | +79.7% | 0.03% | +45.0% |
| Q2 2019 | $914,000 | -35.5% | 24,135 | -33.6% | 0.02% | -35.5% |
| Q1 2019 | $1,417,000 | +242.3% | 36,327 | +232.1% | 0.03% | +287.5% |
| Q2 2018 | $414,000 | -19.6% | 10,939 | -36.2% | 0.01% | -27.3% |
| Q1 2018 | $515,000 | +20.3% | 17,137 | -23.5% | 0.01% | +22.2% |
| Q2 2017 | $428,000 | – | 22,398 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |